Decreasing central line associated bloodstream infection in neonatal intensive care

Clinics in Perinatology

Volumn 37, Issue 1, 2010, Pages 247-272

  Powers, Richard J ^a   Wirtschafter, David W ^b  

^a Good Samaritan Hospital San Jose   (United States)

^b C Michael Neuwelt MD Inc   (United States)

Author keywords

Bloodstream infection; Central line associated bloodstream infection; Nosocomial infection; Quality improvement

Indexed keywords

IMMUNOGLOBULIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BLOOD CULTURE; BREAST FEEDING; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; ENVIRONMENTAL SANITATION; EVIDENCE BASED PRACTICE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL INFECTION; HUMAN; INSTRUMENT STERILIZATION; LEADERSHIP; MEDICAL AUDIT; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; REVIEW; SEPSIS; TEAMWORK; TOTAL QUALITY MANAGEMENT;

BACTEREMIA; BACTERIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; HAND; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; QUALITY ASSURANCE, HEALTH CARE;

EID: 77950919263     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.01.014     Document Type: Review

References (168)

1. Unger A., Goetzman B.W., Chan C., et al. Nutritional practices and outcome of extremely premature infants. Am J Dis Child 1986, 140:1027-1033.
2. Kilbride H.W., Powers R., Wirtschafter D.D., et al. Evaluation and development of potentially better practices to prevent neonatal nosocomial bacteremia. Pediatrics 2003, 111:e504-e518.
3. Kilbride H.W., Wirtschafter D.D., Powers R.J., et al. Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics 2003, 111(4 Pt 2):e519-e533.
4. Carroll J.S., Edmondson A.C. Leading organisational learning in health care. Qual Saf Health Care 2002, 11:51-56.
5. Berwick D.M. The science of improvement. JAMA 2008, 299:1182-1184.
6. Pawson R., Tilley N. Realistic evaluation 1997, Sage Publications, Ltd, London, England.
7. Wenzel R.P. Perspective: attributable mortality: the promise of better antimicrobial therapy. J Infect Dis 1998, 178:917-919.
8. Townsend T.R., Wenzel R.P. Nosocomial bloodstream infections in a newborn intensive care unit: a case-matched control study of morbidity, mortality and risk. Am J Epidemiol 1981, 114:73-80.
9. Pessoa-Silva C.L., Miyasaki C.H., de Almeida M.F., et al. Neonatal late-onset bloodstream infection: attributable mortality, excess of length of stay and risk factors. Eur J Epidemiol 2001, 17:715-720.
10. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
11. Stoll B.J., Hansen N.I., Adams-Chapman I., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
12. Shah D.K., Doyle L.W., Anderson P.J., et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008, 153:170-175. 5 e1.
13. Glass H.C., Bonifacio S.L., Chau V., et al. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 2008, 122:299-305.
14. Back S.A. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 2006, 12:129-140.
15. Lahra M.M., Beeby P.J., Jeffery H.E. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009, 123:1314-1319.
16. Hermans D., Talbotec C., Lacaille F., et al. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007, 44:459-463.
17. Payne N.R., Carpenter J.H., Badger G.J., et al. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004, 114:348-355.
18. Mahieu L.M., Buitenweg N., Beutels P., et al. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect 2001, 47:223-229.
19. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51:1-29.
20. Milisavljevic V., Wu F., Cimmotti J., et al. Genetic relatedness of Staphylococcus epidermidis from infected infants and staff in the neonatal intensive care unit. Am J Infect Control 2005, 33:341-347.
21. Larson E.L. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995, 23:251-269.
22. Labarraque A.G. Instructions and observations regarding the use of chlorides of soda and lime 1829, Baldwin and Treadway, New Haven (CT).
23. Elek S.D. Semmelweis commemoration. Semmelweis and the oath of Hippocrates. Proc R Soc Med 1966, 59:346-352.
24. Ehrenkranz N.J., Alfonso B.C. Failure of bland soap handwash to prevent hand transfer of patient bacteria to urethral catheters. Infect Control Hosp Epidemiol 1991, 12:654-662.
25. Casewell M.W., Dalton M.T., Webster M., et al. Gentamicin-resistant Klebsiella aerogenes in a urological ward. Lancet 1977, 2:444-446.
26. Maki D.G. The use of antiseptics for handwashing by medical personnel. J Chemother 1989, 1(Suppl 1):3-11.
27. Simmons M. Complexity theory in the management of communicable diseases. J Hosp Infect 2003, 54:87-92.
28. Doebbeling B.N., Stanley G.L., Sheetz C.T., et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992, 327:88-93.
29. Webster J., Faoagali J.L., Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994, 30:59-64.
30. Zafar A.B., Butler R.C., Reese D.J., et al. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995, 23:200-208.
31. Larson E.L., Early E., Cloonan P., et al. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000, 26:14-22.
32. Sharek P.J., Benitz W.E., Abel N.J., et al. Effect of an evidence-based hand washing policy on hand washing rates and false-positive coagulase negative staphylococcus blood and cerebrospinal fluid culture rates in a level III NICU. J Perinatol 2002, 22(2):137-143.
33. Marples R.R., Towers A.G. A laboratory model for the investigation of contact transfer of micro-organisms. J Hyg (Lond) 1979, 82:237-248.
34. Mackintosh C.A., Hoffman P.N. An extended model for transfer of micro-organisms via the hands: differences between organisms and the effect of alcohol disinfection. J Hyg (Lond) 1984, 92:345-355.
35. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
36. Ryder M. Improve CRBSI prevention: target intraluminal risks. 2009;(8). Available at: Accessed January 8, 2010. http://www.executivehm.com/article/Improve-CRBSI-Prevention-Target-Intraluminal-Risks/.
37. Eveillard M., Joly-Guillou M.L. 'Measurement and interpretation of hand hygiene compliance rates: importance of monitoring entire care episodes': reply to Professor Gould. J Hosp Infect 2009, 72(3):211-217.
38. Bhalla A., Pultz N.J., Gries D.M., et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004, 25:164-167.
39. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
40. Salzman M.B., Isenberg H.D., Rubin L.G. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993, 31:475-479.
41. Mahieu L.M., De Dooy J.J., Lenaerts A.E., et al. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. J Hosp Infect 2001, 48:20-26.
42. Mahieu L.M., De Muynck A.O., Ieven M.M., et al. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect 2001, 48:108-116.
43. Garland J.S., Alex C.P., Sevallius J.M., et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008, 29:243-249.
44. Salzman M.B., Isenberg H.D., Shapiro J.F., et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993, 167:487-490.
45. Edwards J.R., Peterson K.D., Andrus M.L., et al. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008, 36:609-626.
46. St Geme J.W., Harris M.C. Coagulase-negative staphylococcal infection in the neonate. Clin Perinatol 1991, 18:281-302.
47. Makhoul I.R., Sujov P., Smolkin T., et al. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002, 109:34-39.
48. Nolan T., Berwick D.M. All-or-none measurement raises the bar on performance. JAMA 2006, 295:1168-1170.
49. Levy M.M., Pronovost P.J., Dellinger R.P., et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004, 32:S595-S597.
50. Golombek S.G., Rohan A.J., Parvez B., et al. " Proactive" management of percutaneously inserted central catheters results in decreased incidence of infection in the ELBW population. J Perinatol 2002, 22:209-213.
51. Andersen C., Hart J., Vemgal P., et al. Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect 2005, 61:162-167.
52. Aly H., Herson V., Duncan A., et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics 2005, 115:1513-1518.
53. Schelonka R.L., Scruggs S., Nichols K., et al. Sustained reductions in neonatal nosocomial infection rates following a comprehensive infection control intervention. J Perinatol 2006, 26:176-179.
54. Wirtschafter D.D., Pettit J., Kurtin P., et al. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol 2010, 30:170-181.
55. Lee S.K., Aziz K., Singhal N., et al. Improving the quality of care for infants: a cluster randomized controlled trial. CMAJ 2009, 181:469-476.
56. Lachman P., Yuen S. Using care bundles to prevent infection in neonatal and paediatric ICUs. Curr Opin Infect Dis 2009, 22:224-228.
57. NIH consensus Development Conference on critical care medicine. Crit Care Med 1983, 11:466-469.
58. Sinuff T., Patel R.V., Adhikari N.K., et al. Quality of professional society guidelines and consensus conference statements in critical care. Crit Care Med 2008, 36:1049-1058.
59. Boluyt N., Lincke C.R., Offringa M. Quality of evidence-based pediatric guidelines. Pediatrics 2005, 115:1378-1391.
60. Merritt T.A., Palmer D., Bergman D.A., et al. Clinical practice guidelines in pediatric and newborn medicine: implications for their use in practice. Pediatrics 1997, 99:100-114.
61. Merritt T.A., Gold M., Holland J. A critical evaluation of clinical practice guidelines in neonatal medicine: does their use improve quality and lower costs?. J Eval Clin Pract 1999, 5:169-177.
62. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282:1458-1465.
63. Gurses A.P., Seidl K.L., Vaidya V., et al. Systems ambiguity and guideline compliance: a qualitative study of how intensive care units follow evidence-based guidelines to reduce healthcare-associated infections. Qual Saf Health Care 2008, 17:351-359.
64. Safdar N. Bloodstream infection: an ounce of prevention is a ton of work. Infect Control Hosp Epidemiol 2005, 26:511-514.
65. Borghesi A., Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect 2008, 68:293-300.
66. NHSN patient safety component protocol. January 2008. Available at: Accessed January 8, 2010. http://www.dhcs.ca.gov/provgovpart/initiatives/nqi/Documents/NHSNManPSPCurr.pdf.
67. Schulman J., Wirtschafter D.D., Kurtin P. Neonatal intensive care unit collaboration to decrease hospital-acquired bloodstream infections: from comparative performance reports to improvement networks. Pediatr Clin North Am 2009, 56:865-892.
68. Warye K.L., Murphy D.M. Targeting zero health care-associated infections. Am J Infect Control 2008, 36:683-684.
69. Aboelela S.W., Stone P.W., Larson E.L. Effectiveness of bundled behavioural interventions to control healthcare-associated infections: a systematic review of the literature. J Hosp Infect 2007, 66:101-108.
70. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.
71. Sexton J.B., Helmreich R.L., Neilands T.B., et al. The Safety Attitudes Questionnaire: psychometric properties, benchmarking data, and emerging research. BMC Health Serv Res 2006, 6:44.
72. Pronovost P.J., Berenholtz S.M., Goeschel C., et al. Improving patient safety in intensive care units in Michigan. J Crit Care 2008, 23:207-221.
73. Pronovost P., Sexton B. Assessing safety culture: guidelines and recommendations. Qual Saf Health Care 2005, 14:231-233.
74. Pronovost P.J., Weast B., Bishop K., et al. Senior executive adopt-a-work unit: a model for safety improvement. Jt Comm J Qual Saf 2004, 30:59-68.
75. Thompson D.N., Wolf G.A., Spear S.J. Driving improvement in patient care: lessons from Toyota. J Nurs Adm 2003, 33:585-595.
76. Ojajarvi J. Effectiveness of hand washing and disinfection methods in removing transient bacteria after patient nursing. J Hyg (Lond) 1980, 85:193-203.
77. Ayliffe G.A., Babb J.R., Davies J.G., et al. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988, 11:226-243.
78. Larson E.L., Laughon B.E. Comparison of four antiseptic products containing chlorhexidine gluconate. Antimicrobial Agents Chemother 1987, 31:1572-1574.
79. Kjolen H., Andersen B.M. Handwashing and disinfection of heavily contaminated hands-effective or ineffective?. J Hosp Infect 1992, 21:61-71.
80. Larson E.L., Eke P.I., Laughon B.E. Efficacy of alcohol-based hand rinses under frequent-use conditions. Antimicrobial Agents Chemother 1986, 30:542-544.
81. Winnefeld M., Richard M.A., Drancourt M., et al. Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use. Br J Dermatol 2000, 143:546-550.
82. Boyce J.M., Kelliher S., Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol 2000, 21:442-448.
83. Larson E.L., Aiello A.E., Bastyr J., et al. Assessment of two hand hygiene regimens for intensive care unit personnel. Crit Care Med 2001, 29:944-951.
84. Pittet D., Hugonnet S., Harbarth S., et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000, 356:1307-1312.
85. Goldmann D. System failure versus personal accountability-the case for clean hands. N Engl J Med 2006, 355:121-123.
86. Mermel L.A., McCormick R.D., Springman S.R., et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991, 91:197S-205S.
87. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002, 136:792-801.
88. Garland J.S., Buck R.K., Maloney P., et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995, 14:510-516.
89. Upadhyayula S., Kambalapalli M., Harrison C.J. Safety of anti-infective agents for skin preparation in premature infants. Arch Dis Child 2007, 92:646-647.
90. Lund C.H., Kuller J., Lane A.T., et al. Neonatal skin care: evaluation of the AWHONN/NANN research-based practice project on knowledge and skin care practices. Association of Women's Health, Obstetric and Neonatal Nurses/National Association of Neonatal Nurses. J Obstet Gynecol Neonatal Nurs 2001, 30:30-40.
91. BeVier P.A., Rice C.E. Initiating a pediatric peripherally inserted central catheter and midline catheter program. J Intraven Nurs 1994, 17:201-205.
92. Kyle K.S., Myers J.S. Peripherally inserted central catheters. Development of a hospital-based program. J Intraven Nurs 1990, 13:287-290.
93. Soifer N.E., Borzak S., Edlin B.R., et al. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998, 158:473-477.
94. Linck D.A., Donze A., Hamvas A. Neonatal peripherally inserted central catheter team. Evolution and outcomes of a bedside-nurse-designed program. Adv Neonatal Care 2007, 7:22-29.
95. Butler-O'Hara M., Buzzard C.J., Reubens L., et al. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics 2006, 118:e25-e35.
96. McCarthy M.C., Shives J.K., Robison R.J., et al. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. JPEN J Parenter Enteral Nutr 1987, 11:259-262.
97. Sitges-Serra A., Linares J., Perez J.L., et al. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985, 9:322-325.
98. Arduino M.J., Bland L.A., Danzig L.E., et al. Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control 1997, 25:377-380.
99. Josephson A., Gombert M.E., Sierra M.F., et al. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985, 6:367-370.
100. Maki D.G., Botticelli J.T., LeRoy M.L., et al. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 1987, 258:1777-1781.
101. Snydman D.R., Donnelly-Reidy M., Perry L.K., et al. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987, 8:113-116.
102. Brown J.D., Moss H.A., Elliott T.S. The potential for catheter microbial contamination from a needleless connector. J Hosp Infect 1997, 36:181-189.
103. Luebke M.A., Arduino M.J., Duda D.L., et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998, 26:437-441.
104. Cookson S.T., Ihrig M., O'Mara E.M., et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998, 19:23-27.
105. Donlan R.M., Murga R., Bell M., et al. Protocol for detection of biofilms on needleless connectors attached to central venous catheters. J Clin Microbiol 2001, 39:750-753.
106. Maki D.G., Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987, 258:2396-2403.
107. Hoffmann K.K., Weber D.J., Samsa G.P., et al. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992, 267:2072-2076.
108. Sharpe E.L. Tiny patients, tiny dressings: a guide to the neonatal PICC dressing change. Adv Neonatal Care 2008, 8:150-162. [quiz: 63-4].
109. NANN (National Association of Neonatal Nurses) peripherally inserted central catheters guideline for practice 2007, National Association of Neonatal Nurses, Glenview (IL). 2nd edition. J. Pettit, M. Wyckoff (Eds.).
110. Infusion Nurses Society Infusion nursing standards of practice. J Infus Nurs 2006, 29:1-92.
111. Marschall J., Mermel L.A., Classen D., et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S22-S30.
112. Menyhay S.Z., Maki D.G. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap. Infect Control Hosp Epidemiol 2006, 27:23-27.
113. Kaler W. Successful disinfection of needleless access ports: a matter of time and friction. JAVA 2007, 12:142.
114. Pratt R.J., Pellowe C.M., Wilson J.A., et al. Epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65(Suppl 1):S1-64.
115. Soothill J.S., Bravery K., Ho A., et al. A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward. Am J Infect Control 2009, 37:626-630.
116. Moureau N. Winning the War on CLABSIs: the role of education and new technology. Infection Control Today 2009, Oct:32-36. Available at: http://www.infectioncontroltoday.com/articles/clabsi-education-and-technology.html. Accessed January 8, 2010.
117. Ryder M, Schaudinn C, Gorur A, et al. Microscopic evaluation of microbial colonization on needleless connectors.2008.
118. Murga R., Miller J.M., Donlan R.M. Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol 2001, 39:2294-2297.
119. Donlan R.M. Biofilms on central venous catheters: is eradication possible?. Curr Top Microbiol Immunol 2008, 322:133-161.
120. Hanchett M. Needleless connectors and bacteremia: is there a relationship 2009, 1-8. Available at:, Accessed January 8, 2010. http://www.vpico.com/articlemanager/printerfriendly.aspx?article=60652.
121. Salgado C.D., Chinnes L., Paczesny T.H., et al. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol 2007, 28:684-688.
122. Seymour V.M., Dhallu T.S., Moss H.A., et al. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect 2000, 45:165-168.
123. Edgar K.J. Does the evidence support the SHEA-IDSA recommendation on the use of positive-pressure mechanical valves?. Infect Control Hosp Epidemiol 2009, 30:402-403. [author reply: 3-4].
124. Chathas M.K., Paton J.B., Fisher D.E. Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child 1990, 144:1246-1250.
125. Durand M., Ramanathan R., Martinelli B., et al. Prospective evaluation of percutaneous central venous silastic catheters in newborn infants with birth weights of 510 to 3,920 grams. Pediatrics 1986, 78:245-250.
126. Cairns P.A., Wilson D.C., McClure B.G., et al. Percutaneous central venous catheter use in the very low birth weight neonate. Eur J Pediatr 1995, 154:145-147.
127. Vest J.R., Gamm L.D. A critical review of the research literature on Six Sigma, Lean and StuderGroup's Hardwiring Excellence in the United States: the need to demonstrate and communicate the effectiveness of transformation strategies in healthcare. Implement Sci 2009, 4:35.
128. Griffiths P., Renz A., Hughes J., et al. Impact of organisation and management factors on infection control in hospitals: a scoping review. J Hosp Infect 2009, 73:1-14.
129. Shannon R.P., Frndak D., Grunden N., et al. Using real-time problem solving to eliminate central line infections. Jt Comm J Qual Saf 2006, 32:479-487.
130. Stapleton F.B., Hendricks J., Hagan P., et al. Modifying the Toyota Production System for continuous performance improvement in an academic children's hospital. Pediatr Clin North Am 2009, 56:799-813.
131. Murphy B. Evidence-based leadership for reduced risk. Managing Infection Control 2007, (7):64-72.
132. Nelson E.C., Batalden P.B., Godfrey M.M. Quality by design-a clinical microsystems approach 2007, John Wiley and Sons, Inc., Hoboken (NJ).
133. Clinical microsystems Available at:, Accessed November 1, 2009. http://dms.dartmouth.edu/cms/.
134. Batalden P.B., Nelson E.C., Edwards W.H., et al. Microsystems in health care: Part 9. Developing small clinical units to attain peak performance. Jt Comm J Qual Saf 2003, 29:575-585.
135. Edwards W.H. Preventing nosocomial bloodstream infection in very low birth weight infants. Semin Neonatol 2002, 7:325-333.
136. Caldwell C. Mentoring strategic change in health care: an action guide 1995, ASQC Quality Press, Milwaukee (WI).
137. California Perinatal Quality Care Collaborative Quality Improvement. Available at:, Accessed November 1, 2009. http://www.cpqcc.org/quality_improvement.
138. Horbar J.D., Plsek P.E., Leahy K. NIC/Q 2000: establishing habits for improvement in neonatal intensive care units. Pediatrics 2003, 111:e397-e410.
139. Bohmer R.M., Edmondson A.C. Organizational learning in health care. Health Forum J 2001, 44:32-35.
140. Ayers L.R., Beyea S.C., Godfrey M.M., et al. Quality improvement learning collaboratives. Qual Manag Health Care 2005, 14:234-247.
141. Randolph G., Esporas M., Provost L., et al. Model for improvement-Part two: measurement and feedback for quality improvement efforts. Pediatr Clin North Am 2009, 56:779-798.
142. Kurtin P., Stucky E. Standardize to excellence: improving the quality and safety of care with clinical pathways. Pediatr Clin North Am 2009, 56:893-904.
143. Haas J.P., Larson E.L. Measurement of compliance with hand hygiene. J Hosp Infect 2007, 66:6-14.
144. Allegranzi B., Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect 2009, 73(4):305-315.
145. van de Mortel T., Murgo M. An examination of covert observation and solution audit as tools to measure the success of hand hygiene interventions. Am J Infect Control 2006, 34(3):95-99.
146. McGuckin M., Waterman R., Govednik J. Hand hygiene compliance rates in the United States-a one-year multicenter collaboration using product/volume usage measurement and feedback. Am J Med Qual 2009, 24:205-213.
147. Luria J.W., Muething S.E., Schoettker P.J., et al. Reliability science and patient safety. Pediatr Clin North Am 2006, 53:1121-1133.
148. Shapiro M.J., Jay G.D. High reliability organizational change for hospitals: translating tenets for medical professionals. Qual Saf Health Care 2003, 12:238-239.
149. Berenholtz S.M., Hartsell T.L., Pronovost P.J. Learning from defects to enhance morbidity and mortality conferences. Am J Med Qual 2009, 24:192-195.
150. Pronovost P.J., Berenholtz S.M., Goeschel C.A., et al. Creating high reliability in health care organizations. Health Serv Res 2006, 41:1599-1617.
151. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev 2001, (2). CD000361.
152. Craft A., Finer N. Nosocomial coagulase negative staphylococcal (CoNS) catheter-related sepsis in preterm infants: definition, diagnosis, prophylaxis, and prevention. J Perinatol 2001, 21:186-192.
153. Garland J.S., Alex C.P., Henrickson K.J., et al. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 2005, 116:e198-e205.
154. de Silva A., Jones P.W., Spencer S.A. Does human milk reduce infection rates in preterm infants? A systematic review. Arch Dis Child Fetal Neonatal Ed 2004, 89:F509-F513.
155. Ben X.M. Nutritional management of newborn infants: practical guidelines. World J Gastroenterol 2008, 14:6133-6139.
156. Troche B., Harvey-Wilkes K., Engle W.D., et al. Early minimal feedings promote growth in critically ill premature infants. Biol Neonate 1995, 67:172-181.
157. Freeman J., Goldmann D.A., Smith N.E., et al. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990, 323:301-308.
158. Avila-Figueroa C., Goldmann D.A., Richardson D.K., et al. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J 1998, 17:10-17.
159. Melly M.A., Meng H.C., Schaffner W. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg 1975, 110:1479-1481.
160. Abdelkefi A., Achour W., Ben Othman T., et al. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. J Support Oncol 2007, 5:273-278.
161. Shah P.S., Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database Syst Rev 2007, (4). CD005983.
162. Williams D. Catheters, materials and infection. Med Device Technol 2002, 13:8-11.
163. Yasukawa T., Fujita Y., Sari A. Antimicrobial-impregnated central venous catheters. N Engl J Med 1999, 340:1762.
164. Ranucci M., Isgro G., Giomarelli P.P., et al. Impact of Oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003, 31:52-59.
165. Garland J.S., Alex C.P., Mueller C.D., et al. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatr Infect Dis J 1996, 15:912-914.
166. Crnich C.J., Maki D.G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002, 34:1232-1242.
167. Khattak A.Z., Ross R.E., Arnold C., et al. A randomized controlled trial of the safety of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. J Perinatol 2009, [Epub ahead of print].
168. Curry S., Honeycutt M., Goins G., et al. Catheter-associated bloodstream infections in the NICU: getting to zero. Neonatal Netw 2009, 28(3):151-155.